Switch to:
More From Other Websites
3 Dividend Stocks That Thrive in Market Crashes May 27 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Amgen Inc. and Encourages... May 26 2017
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Amgen Inc. Investors May 26 2017
Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote May 26 2017
Nplate and Vectibix Could Contribute to Amgen’s Revenue Growth in 2017 May 26 2017
[$$] Harpoon Therapeutics Snares $45 Million Series B for Prostate Cancer Treatment May 25 2017
These 5 Healthcare Stocks Are Undervalued May 25 2017
Could There Be a Revenue Fall for Neulasta in 2017? May 25 2017
A Look At Nvidia's Largest Shareholders And What Their Presence Means May 25 2017
Short Sellers Raise the Stakes in Major Biotechs May 25 2017
The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene May 25 2017
Radius Health Osteoporosis Drug Positive in Phase III Study May 25 2017
Exploring Kyprolis’s Revenue Trend in 2017 May 25 2017
Drug approvals bounce back as R&D labs churn out new winners May 25 2017
Kyprolis Could Significantly Drive Amgen’s Revenue Growth in 2017 May 25 2017
3 Reasons Gilead Sciences, Inc. Is a Better Dividend Stock Than Amgen, Inc. May 24 2017
Third Avenue Continues to Buy Amgen, 8 Others May 24 2017
Neupogen and Enbrel Could See Falling Revenues in 2017 May 24 2017
Biosimilars Could Become a Key Long-Term Growth Driver for Amgen May 24 2017
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data May 24 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK